G Protein-Coupled Receptors as Targets for Approved Drugs: How Many Targets and How Many Drugs?

2018/01/03 by Krishna Sriram, Paul A. Insel · 1,305 citations
Biochemistry, Genetics and Molecular Biology · Computer Science · Pharmacology, Toxicology and Pharmaceutics · #Bioinformatics #Biology #Computational Drug Discovery Methods #Computational biology #Drug #Drug discovery #DrugBank #G protein-coupled receptor #Genetics #Pharmacogenetics and Drug Metabolism #Pharmacology #Receptor #Receptor Mechanisms and Signaling #chEMBL

paper · pdf · doi:10.1124/mol.117.111062

published in Molecular Pharmacology 93(4), 251-258 (American Society for Pharmacology and Experimental Therapeutics)

openalex publication_date 2018/01/03 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/06

Cited by

• Design of allosteric modulators that change GPCR G protein subtype selectivity
• Nanodomain cAMP signaling in cardiac pathophysiology: potential for developing targeted therapeutic interventions
• Advantages and shortcomings of cell-based electrical impedance measurements as a GPCR drug discovery tool
• How accurately can one predict drug binding modes using AlphaFold models?
• Chemical biology approaches to resolve the subcellular GPCR signaling landscape
• Biased signaling in drug discovery and precision medicine
• Using AlphaFold and Experimental Structures for the Prediction of the Structure and Binding Affinities of GPCR Complexes via Induced Fit Docking and Free Energy Perturbation
• Ghrelin receptor signaling in health and disease: a biased view
• Cell-Free Systems and Their Importance in the Study of Membrane Proteins
• A positive allosteric modulator of the β1AR with antagonist activity for catecholaminergic polymorphic ventricular tachycardia
• Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery
• Physiological functions and structural features of Gα12/13 proteins
• The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
• An amphipol‐stabilized multi‐pass transmembrane protein as an immunogen to generate mouse memory B cells against native VMAT 2
• Membrane Protein Complexity Revealed Through Native Mass Spectrometry
• Mechanisms governing GPCR anterograde transport
• Applications of machine learning in GPCR bioactive ligand discovery
• Characterizing conformational states in GPCR structures using machine learning
• Using AlphaFold and Experimental Structures for the Prediction of the Structure and Binding Affinities of GPCR Complexes via Induced Fit Docking and Free Energy Perturbation
• Exploring G Protein-Coupled Receptors (GPCRs) Ligand Space via Cheminformatics Approaches: Impact on Rational Drug Design. [europepmc]
• GPCRomics: GPCR Expression in Cancer Cells and Tumors Identifies New, Potential Biomarkers and Therapeutic Targets. [europepmc]
• White shark genome reveals ancient elasmobranch adaptations associated with wound healing and the maintenance of genome stability. [europepmc]
• GPCRomics: An Approach to Discover GPCR Drug Targets. [europepmc]
• Mapping Interactions of Microbial Metabolites with Human G-Protein-Coupled Receptors. [europepmc]
• Insights into Membrane Protein-Lipid Interactions from Free Energy Calculations. [europepmc]
• Proximal Tubule Translational Profiling during Kidney Fibrosis Reveals Proinflammatory and Long Noncoding RNA Expression Patterns with Sexual Dimorphism. [europepmc]
• Regulator of G-protein signaling (RGS) proteins as drug targets: Progress and future potentials. [europepmc]
• G-Protein-Coupled Receptors in CNS: A Potential Therapeutic Target for Intervention in Neurodegenerative Disorders and Associated Cognitive Deficits. [europepmc]
• Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies. [europepmc]
• Structural and Biophysical Mechanisms of Class C G Protein-Coupled Receptor Function. [europepmc]
• Combinatorial expression of GPCR isoforms affects signalling and drug responses. [europepmc]
• Post-Translational Modifications of G Protein-Coupled Receptors Control Cellular Signaling Dynamics in Space and Time. [europepmc]
• G protein-coupled receptors: structure- and function-based drug discovery. [europepmc]
• Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery. [europepmc]
• SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation. [europepmc]
• GPCR activation mechanisms across classes and macro/microscales. [europepmc]
• GPCR kinase knockout cells reveal the impact of individual GRKs on arrestin binding and GPCR regulation. [europepmc]
• Community guidelines for GPCR ligand bias: IUPHAR review 32. [europepmc]
• The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer. [europepmc]
• Short-Chain Fatty Acid Receptors and Cardiovascular Function. [europepmc]
• GPCR-mediated β-arrestin activation deconvoluted with single-molecule precision. [europepmc]
• Protein Design: From the Aspect of Water Solubility and Stability. [europepmc]
• G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders. [europepmc]
• G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery. [europepmc]